Skip to main content

Future Outlook of the Non-viral Gene Delivery Technologies Market: Analyzing Size, Share, Growth Patterns

The global non-viral gene delivery technologies market size is anticipated to reach USD 7.11 billion by 2030 and grow at a CAGR of 12.29% from 2025 to 2030 during the forecast period, according to a new report by Grand View Research, Inc. The market's growth is driven by the growing demand for safe, scalable, and cost-effective alternatives to viral vectors in gene therapy and research. Unlike viral methods, non-viral technologies such as lipid nanoparticles (LNPs), polymers, and electroporation offer lower immunogenicity and reduced manufacturing complexities. These attributes make them highly suitable for large-scale applications, including mRNA-based vaccines and CRISPR/Cas9-based gene editing therapies. The success of mRNA COVID-19 vaccines by Moderna and Pfizer-BioNTech further validated the potential of non-viral delivery systems, spurring global investment in this sector.

Advancements in nanotechnology and biomaterials are further accelerating innovation in the field. Nanoparticles, lipoplexes, and hybrid carriers are being optimized for enhanced transfection efficiency and targeted delivery. With the rising prevalence of chronic diseases, including cancer, rare genetic disorders, and cardiovascular conditions, the need for effective and precise therapeutic solutions has surged. Non-viral technologies, with their ability to deliver large genetic payloads and support repeat administrations, are pivotal in addressing these unmet medical needs. In addition, their versatility in both in vitro research applications and in vivo therapeutic use cases expands their adoption across biotechnology, pharmaceutical companies, and academic institutes.

The rising government funding and private investments in gene therapy research are also key drivers of market growth. Regions like North America and Europe lead in terms of R&D, but emerging economies in Asia-Pacific, such as China and India, are rapidly advancing due to increasing biotech infrastructure and supportive regulatory frameworks. Furthermore, partnerships between biotech companies and academic institutions are fostering innovation and expanding the accessibility of non-viral delivery solutions, ensuring their relevance in the rapidly evolving field of gene therapy.

For More Details or Sample Copy please visit link @: Non-viral Gene Delivery Technologies Market Report

Non-viral Gene Delivery Technologies Market Report Highlights

  • The chemical segment accounted for the largest revenue share in 2024 and is projected to witness the fastest growth rate over the forecast period. The chemical mode of non-viral gene delivery technologies is driven by the increasing demand for efficient, safe, and scalable gene delivery systems.
  • In 2024, research dominated the market with the largest revenue share, driven by the increasing demand for versatile, efficient, and cost-effective tools to investigate gene function, expression, and regulation.
  • By end use, the research and academic institutes segment captured the largest revenue share of 48.11% in 2024 and is expected to experience the fastest CAGR during the forecast period. This growth is fueled by the rising demand for reliable, efficient, and cost-effective approaches to study gene function, expression, and modification.  
  • The North American region dominated globally with a market share of 41.25% in 2024. The region benefits from advanced healthcare infrastructure, enabling the rapid adoption of innovative gene delivery techniques. Growing interest in precision medicine and increasing clinical trials focused on genetic disorders further boost market growth. In addition, government initiatives and funding for genomic research contribute to the expanding use of non-viral delivery technologies.

Non-viral Gene Delivery Technologies Market Segmentation

Grand View Research has segmented the global non-viral gene delivery technologies market based on mode, application, end-use, and region:

Non-viral Gene Delivery Technologies Mode Outlook (Revenue, USD Million, 2018 - 2030)

  • Chemical
    • LNPs
    • Polymers
    • Others
  • Physical
    • Electroporation
    • Microinjection
    • Others

Non-viral Gene Delivery Technologies Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Research
  • Therapeutics
    • Gene Therapy
    • Cell Therapy
    • Vaccines

Non-viral Gene Delivery Technologies End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Biotechnology and Biopharmaceutical Companies
  • Research and Academic Institutes
  • Others

Research Methodology

We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.

About Grand View Research      

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

 

#GeneDelivery #GeneTherapy #Biotechnology #Biomaterials #PersonalizedMedicine #DrugDelivery #MedicalDevices #CellTherapy #PrecisionMedicine #CRISPR and #GenomicMedicine

Comments

Popular posts from this blog

Welded Plate And Block Heat Exchanger Market Segments & Scope Analysis & Growth Forecast

  The global  welded plate and block heat exchanger market  size is anticipated to reach USD 1.2 billion by 2025, exhibiting a CAGR of 5.9% over the forecast period, according to a new report published by Grand View Research, Inc. The market is anticipated to be driven by the growing demand for the product in HVAC & refrigeration, power generation, and petrochemical industries, especially in emerging economies in Asia Pacific and CSA regions. Welded plate & block heat exchangers play a significant role in enhancing heat transfer efficiency of industrial machinery. Growing demand for efficient thermal management systems with low space requirements is expected to drive the demand for plate & block heat exchangers over the forecast period. Growth of industrial sectors including food & beverages, chemicals, pulp & paper, power generation, metal & mining, textiles, and oil & gas is leading to an increase in the requirement for highly-efficient...

Comprehensive Analysis of the Digital Media Market: Size, Share, Growth Trends

  The global  digital media market  size is expected to reach USD 1,902.28 billion by 2030 and is anticipated to grow at a CAGR of 12.8% from 2024 to 2030, according to a new study by Grand View Research, Inc. Increasing internet penetration and rising smartphone usage have fueled the demand for digital content, further driving the market expansion. The proliferation of high-speed internet and the widespread adoption of smartphones have made digital media more accessible than ever before. In addition, the rise of social media platforms has revolutionized content consumption, providing users with personalized and engaging experiences. Moreover, advancements in artificial intelligence and machine learning are enabling content creators to produce more sophisticated and targeted media, enhancing user engagement and satisfaction. These factors are collectively propelling the market growth. Digital Media Market Report Highlights Based on content type, t...

Generative AI In Agriculture Market Overview: Extensive Evaluation of Market Size, Growth Opportunities

  The global   generative AI in agriculture market   size was estimated at USD 226.2 million in 2024 and is projected to reach USD 2,158.9 million by 2033, growing at a CAGR of 28.7% from 2025 to 2033. Farmers are increasingly using generative models to predict yields, weather impacts, and input requirements. This trend supports precision agriculture by enabling scenario-based planning. The global generative AI in agriculture industry is witnessing a shift toward AI-driven crop simulation and decision-making tools. The development of specialized, accessible, and efficient AI models for agricultural advisory, yield prediction, and climate adaptation is driving growth in the generative AI in agriculture market. This indicates growing demand for localized, multilingual, and climate-resilient advisory tools, especially for smallholder farmers in emerging regions, and signals a shift from general-purpose AI to frugal, scalable solutions suited for underserved agricul...